Sumatriptan Succinate Injection
Product Images NDC 46708-657

Product Visual Gallery

This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Sumatriptan Succinate (NDC 46708-657). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sumatriptan-4mg-carton-1s (Sumatriptan 4mg Carton 1s)

Packaging label for Sumatriptan Injection, USP 4 mg/0.5 mL subcutaneous injection by Alembic Pharmaceuticals Limited. The carton includes a single-dose prefilled autoinjector syringe containing 0.5 mL solution. The label features injection instructions and storage info, with branding and a barcode displayed.*

FDA Label Image

Sumatriptan-4mg-carton-2s (Sumatriptan 4mg Carton 2s)

Packaging label for Sumatriptan Injection, USP 4 mg/0.5 mL, a subcutaneous injection by Alembic Pharmaceuticals Limited. The carton contains 2 prefilled syringes (0.5 mL each) of sumatriptan injection in a single dose autoinjector system. The label includes preparation instructions and storage conditions.*

FDA Label Image

Sumatriptan-4mg-pen-label (Sumatriptan 4mg Pen Label)

Label for Sumatriptan Injection, USP 4 mg/0.5 mL subcutaneous injection by Alembic Pharmaceuticals Limited. Single dose autoinjector system with 0.5 mL prefilled syringe containing 5.6 mg sumatriptan succinate equivalent to 4 mg sumatriptan. Label includes storage instructions, barcode, and manufacturing details from Gujarat, India.*

FDA Label Image

Sumatriptan-4mg (Sumatriptan 4mg)

Sumatriptan Succinate 6 mg/0.5 mL subcutaneous injection in a prefilled autoinjector syringe. The label shows the proprietary name and dosage strength. The product is manufactured by Alembic Pharmaceuticals Limited.*

FDA Label Image

Sumatriptan-6mg-carton-1s (Sumatriptan 6mg Carton 1s)

Packaging label for Sumatriptan Injection, USP 6 mg/0.5 mL by Alembic Pharmaceuticals Limited. The label details a single-dose auto-injector prefilled syringe for subcutaneous injection with usage instructions. It includes storage information, prescribing info reminders, and a barcode. The carton contains one 0.5 mL prefilled syringe of sumatriptan succinate injection.*

FDA Label Image

Sumatriptan-6mg-carton-2s (Sumatriptan 6mg Carton 2s)

Packaging label for Sumatriptan Injection, USP 6 mg/0.5 mL subcutaneous injection by Alembic Pharmaceuticals Limited. It is a single-dose autoinjector system containing 2 prefilled syringes of 0.5 mL. The label includes directions for use illustrations and storage instructions, highlighting that the product is sterile and nonpyrogenic.*

FDA Label Image

Sumatriptan-6mg-pen-label (Sumatriptan 6mg Pen Label)

Label for Sumatriptan Injection, USP 6 mg/0.5 mL by Alembic Pharmaceuticals Limited. It is a single-dose subcutaneous injection autoinjector system containing 6 mg sumatriptan succinate in 0.5 mL solution. The label includes storage instructions, barcode, lot and expiration date fields.*

FDA Label Image

Sumatriptan-6mg (Sumatriptan 6mg)

Sumatriptan Succinate injection pen labeled for subcutaneous use, containing 6 mg/0.5 mL strength. The pen is white with a blue cap on one end and a clear protective cover over the needle on the other. The product is manufactured by Alembic Pharmaceuticals Limited.*

FDA Label Image

Sumatriptan-features2 (Sumatriptan Features2)

Illustration showing a pre-filled auto-injector for subcutaneous injection of Sumatriptan Succinate in three stages: a) with the cap on before injection, b) after cap removal before injection, and c) after the injection is completed.*

FDA Label Image

Sumatriptan-figure-1 (Sumatriptan Figure 1)

A line graph comparing the estimated percentage of patients with relief over time (0 to 25 minutes) for Sumatriptan versus placebo. The graph shows two lines: one with circular markers representing Sumatriptan with a higher relief percentage increasing steadily, and another with square markers representing placebo with a lower relief percentage increasing more slowly. The x-axis is labeled 'Time (min.)' and the y-axis 'Estimated % of Patients with Relief.'*

FDA Label Image

Sumatriptan-ifu-fig-a (Sumatriptan Ifu Fig A)

An instructional illustration showing a hand wearing a glove holding a sumatriptan succinate injection pen. The image highlights a close-up of the needle area with an eye symbol indicating visual check before use, likely emphasizing inspection of the injection site or device prior to administration.*

FDA Label Image

Sumatriptan-ifu-fig-b (Sumatriptan Ifu Fig B)

An anatomical illustration showing injection sites for subcutaneous administration on the human body. Labeled areas include the upper arms (marked with '2') and the upper outer thighs or buttocks (marked with '1'), indicating recommended locations for sumatriptan succinate injection.*

FDA Label Image

Sumatriptan-ifu-fig-c (Sumatriptan Ifu Fig C)

An instructional illustration demonstrating the subcutaneous injection technique. It shows a hand pinching the skin on the outer thigh of a bent leg, preparing the injection site for administering the sumatriptan succinate injection.*

FDA Label Image

Sumatriptan-ifu-fig-d (Sumatriptan Ifu Fig D)

An instructional illustration showing hands preparing a subcutaneous injection. One hand holds a syringe labeled with measurements, while the other hand removes or attaches a cap from the syringe needle. The image demonstrates the step of prepping the injection device before administration.*

FDA Label Image

Sumatriptan-ifu-fig-e (Sumatriptan Ifu Fig E)

An illustration showing the proper and improper handling of a device tip for a subcutaneous injection. The left panel with a checkmark indicates the correct way to hold or use the device, while the right panel with an X indicates an incorrect method. The device appears to be an injection pen or similar applicator, with focus on the tip orientation.*

FDA Label Image

Sumatriptan-ifu-fig-f (Sumatriptan Ifu Fig F)

An instructional illustration showing a hand holding a subcutaneous injection device at a 90-degree angle to the skin, demonstrating the proper technique for administering a subcutaneous injection of Sumatriptan Succinate.*

FDA Label Image

Sumatriptan-ifu-fig-g (Sumatriptan Ifu Fig G)

An instructional illustration showing a hand holding a sumatriptan succinate injection device at a 90-degree angle against the skin for subcutaneous administration, followed by an image of pressing down on the device to deliver the injection.*

FDA Label Image

Sumatriptan-ifu-fig-h (Sumatriptan Ifu Fig H)

An instructional illustration showing a gloved hand gripping a syringe-like device for subcutaneous injection, with a downward arrow indicating pressing action and a clock icon displaying 5 seconds, likely demonstrating how to administer the injection correctly.*

FDA Label Image

Sumatriptan-ifu-fig-i (Sumatriptan Ifu Fig I)

An instructional illustration showing two views of a subcutaneous injection device for sumatriptan succinate. The left image depicts the device in an initial state, while the right image shows the device with the syringe plunger depressed, linked by a right-pointing arrow indicating the injection process.*

FDA Label Image

Sumatriptan-ifu-fig-j. (Sumatriptan Ifu Fig J)

An instructional illustration showing how to administer a subcutaneous injection of Sumatriptan Succinate. It depicts a hand holding a syringe at a 90-degree angle to the skin, with arrows indicating the direction to insert and withdraw the needle.*

FDA Label Image

Sumatriptan-ifu-fig-k (Sumatriptan Ifu Fig K)

An instructional illustration showing a gloved hand disposing of a used injection device into a sharps disposal container by pressing it downward into the container's opening.*

FDA Label Image

Sumatriptan-structure (Sumatriptan Structure)

Chemical structure of sumatriptan succinate is shown, depicting the molecular arrangement of atoms and bonds characteristic to this active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.